共 50 条
- [41] Phase I Study of Hypofractionated Intensity Modulated Radiation Therapy with Concurrent and Adjuvant Temozolomide in Patients with Glioblastoma MultiformeINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S168 - S168Jastaniyah, N. T.Le, D.Pervez, N.Roa, W.Murtha, A.Patel, S.Mackenzie, M.Fulton, D.Field, C.Fallone, G.
- [42] SORAFENIB (SO) IN ASSOCIATION WITH LOW-DOSE METRONOMIC TEMOZOLOMIDE (TMZ) IN RECURRENT GLIOBLASTOMA MULTIFORME (GBM): PRELIMINARY RESULTS OF A PHASE II STUDYANNALS OF ONCOLOGY, 2010, 21 : 330 - 331Landi, L.Zustovich, F.Galli, C.Lombardi, G.Galli, L.Amoroso, D.Porta, C.Fontana, A.Andreuccetti, M.Falcone, A.
- [43] Phase I study of AZD1775 with radiation therapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM) and evaluation of intratumoral drug distribution (IDD) in patients with recurrent GBM.JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Alexander, Brian MichaelAhluwalia, Manmeet SinghDesai, Arati SuvasDietrich, JorgKaley, Thomas JosephPeereboom, David M.Takebe, NaokoSupko, Jeffrey G.Desideri, SerenaFisher, Joy D.Sims, MeganYe, XiaobuNabors, Louis B.Grossman, Stuart A.Wen, Patrick Y.
- [44] Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II studyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S162 - S163Athanassiou, HSynodinou, MMaragoudakis, EParaskevaidis, MVerigos, CMisailidou, DAntonadou, DSarris, GBeroukas, KKarageorgis, P
- [45] Clinical and genetic factors associated with severe myelotoxicity during radiation therapy (RI) plus temozolomide (TMZ) in glioblastoma (GBM) patients: A prospective observational studyEUROPEAN JOURNAL OF CANCER, 2013, 49 : S790 - S790Lombardi, G.Rumiato, E.Farina, P.Bertorelle, R.Saggioro, D.Zustovich, F.Della Puppa, A.Berti, F.Vittorina, Z.
- [46] PHASE II TRIAL OF UPFRONT BEVACIZUMAB WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)NEURO-ONCOLOGY, 2012, 14 : 79 - 79Ranjan, TulikaDesjardins, AnnickPeters, Katherine B.Alderson, LloydKirkpatrick, JohnHerndon, James, IIBailey, LeighannSampson, JohnFriedman, Allan H.Friedman, HenryVredenburgh, James J.
- [47] BEVACIZUMAB (BV) IN COMBINATION TO TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): A PHASE 2 TRIALNEURO-ONCOLOGY, 2009, 11 (05) : 634 - 634Desjardins, AnnickReardon, David A.Peters, Katherine B.Herndon, JamesKirkpatrick, JohnGururangan, SridharanSampson, John H.Friedman, Allan H.Friedman, HenryVredenburgh, James J.
- [48] NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progressASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 196 - 197Khasraw, MustafaMcDonald, Kerrie L.Yip, SoniaVerhaak, RoelHeimberger, AmyHall, MerrynFisher, LaurenBarnes, ElizabethRosenthal, MarkGedye, CraigHovey, ElizabethEllingson, Benjamin M.Simes, JohnTongela, AnnetteWheeler, HelenKoh, Eng-SiewGan, HuiBack, MichaelLwin, Zarnie
- [49] NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESSNEURO-ONCOLOGY, 2018, 20 : 235 - 235Khasraw, MustafaMcDonald, KerrieYip, SoniaVerhaak, RoelHeimberger, AmyHall, MerrynFisher, LaurenBarnes, ElizabethRosenthal, MarkGedye, CraigHovey, ElizabethEllingson, BenjaminSimes, JohnTognela, AnnetteKoh, Eng-SiewGan, HuiBack, MichaelLwin, Zarnie
- [50] Phase 1b/2 study of pexidartinib (PEX) in combination with radiation therapy (XRT) and temozolomide (TMZ) in newly diagnosed glioblastoma.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Colman, HowardRaizer, Jeffrey J.Walbert, TobiasPlotkin, Scott RandallChamberlain, Marc C.Wong, Eric T.